Results 201 to 210 of about 89,228 (352)

THE PATTERN OF HEARING LOSS AS SEEN AT THE UNIVERSITY OF BENIN TEACHING HOSPITAL, BENIN CITY, NIGERIA

Gomal Journal of Medical Sciences, 2014
Background: Hearing loss is a major cause of disability in developing countries. It presents with enormous problems in Nigeria. The objectives of this study were to determine the gender and age distribution, types, severity and the aetiological factors
Paul Roosvelt Oserhemhen Chukwuemeka Adobamen
doaj  

Periostin as a marker of mucosal remodelling in chronic rhinosinusitis

, 2017
J.A. Ebenezer, J.M. Christensen, Brian G. Oliver, R.A. Oliver, Gavin Tjin, Jacqueline Ho, A.R. Habib, J. Rimmer, Raymond Sacks, Richard J. Harvey   +9 more
openalex   +2 more sources

Targeting Immunologic Pathways in Eosinophilic Granulomatosis With Polyangiitis: Translating Emerging Evidence Into Clinical Practice

Allergy, EarlyView.
ABSTRACT Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare and potentially life‐threatening systemic, inflammatory disease with multi‐organ manifestations, variable presentation and complex pathology. Multiple interconnected immunological pathways are implicated in EGPA pathology, including a type‐2 immune response driving predominantly ...
Harold Wilson‐Morkeh, Lior Seluk, Philipp Bosch, Carolina Aguiar, Jens Thiel, Bernhard Hellmich, Michael E. Wechsler, Salman Siddiqui   +7 more
wiley   +1 more source

Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis.

Journal of Allergy and Clinical Immunology: In Practice, 2019
W. Stevens, Anju T Peters, B. Tan, Aiko I. Klingler, J. Poposki, K. Hulse, L. Grammer, Kevin C. Welch, Stephanie S. Smith, D. Conley, R. Kern, R. Schleimer, A. Kato   +12 more
semanticscholar   +1 more source

Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help? [PDF]

, 2014
Bhutta, Mahmood, Blackshaw (UCL), Helen, Philpott, Carl, Schilder, Anne   +3 more
core   +1 more source

Allergic Sensitization to Inhalant Allergens in the Upper Respiratory Tract—the B Cell Side

Allergy, EarlyView.
ABSTRACT Allergic diseases are on the rise worldwide, driven by respiratory epithelial barrier dysfunction that promotes sensitization to inhalant allergens such as pollen, dust mites, pet dander, and fungal spores. These antigens trigger IgE‐mediated immune responses that lead to diseases such as allergic rhinitis (AR) and asthma.
Ola Grimsholm, Mohammed Zghaebi, Bita Hambrecht, Tanja Kalic, Christopher C. Udoye, Rudolf Manz, Barbara Bohle, Katarzyna M. Sitnik, Julia Eckl‐Dorna, Heimo Breiteneder   +9 more
wiley   +1 more source

Editorial: Recent advances in rhinology 2024. [PDF]

Front Allergy
Conti DM, Scadding GK.
europepmc   +1 more source

A study of the efficacy and safety of new cephalosporin in the treatment of acute bacterial rhinosinusitis

, 2016
Е. Л. Савлевич, V S Kozlov, M. A. ZHARKYKH   +2 more
openalex   +1 more source

Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2

Clinical &Experimental Allergy, EarlyView.
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz, Thomas Rothe, Lieven Dupont, Trung N. Tran, Andrew Menzies‐Gow, Anat Shavit, David Cohen, Tanja Plate, Sheena Kayaniyil, An Herreman, Claudio Schuoler, Benjamin Emmanuel, Marek Lommatzsch   +12 more
wiley   +1 more source

Dupilumab Dampens Mucosal Type 2 Response During Acetylsalicylic Acid Challenge in N‐ERD Patients

Clinical &Experimental Allergy, EarlyView.
Dupilumab therapy reduced elevated type 2 cytokine responses post‐ASA provocation in N‐ERD patients, independent of ASA tolerance, and revealed novel mechanistic insights by modulating acute type 2 immunity. Transcriptomic analysis showed concurrent downregulation of lipid and peroxisome pathways during ASA challenge in N‐ERD patients after 24 weeks of
Julia Eckl‐Dorna, Christina Morgenstern, Katharina Poglitsch, Tamara Arnoldner, Katharina Gangl, Tina J. Bartosik, Nicholas J. Campion, Aldine Tu, Victoria Stanek, Sven Schneider, Christine Bangert   +10 more
wiley   +1 more source